Higher daily walking steps were associated with reduced morning systolic and diastolic blood pressure over a mean follow-up of 378 days in 69 hypertensive patients.
Observational (n=69)
Does higher daily walking monitored via a telemedicine system reduce blood pressure in hypertensive patients?
A telemedicine system monitoring daily walking steps confirmed that higher step counts are associated with reduced blood pressure and improved body composition in hypertensive patients.
BACKGROUND: Regular physical activity (PA), including daily walking, reduces the risk of many chronic diseases, especially hypertension. Pedometer is a potential motivational aid for increasing PA. In the present study, we used a telemedicine system and analyzed the relationship between daily walking, calculated by pedometers, and blood pressure (BP). METHODS: BP was measured at home twice a day (morning and evening) using an oscillometric automatic device. Body weight (BW) and percent body fat (%BF) were measured after BP measurement. Daily walking steps (DWS) were calculated by a pedometer. These daily parameters were transmitted through the Internet to a central server computer and sent to the Medical Health Center. RESULTS: Sixty-nine (N = 69) hypertensive patients were included in this study. The mean follow-up period was 378 days. Electronic data from a pedometer (DWS) were associated with reduced BW, body mass index, and %BF. Hypertensive patients were divided into two groups based on the DWS. In the high DWS group, morning systolic BP and diastolic BP and evening systolic BP were reduced after induction of the telemedicine system. CONCLUSION: A telemedicine system confirmed the usefulness of walking to control BP in hypertensive patients.
Okura et al. (Wed,) conducted a observational in Hypertension (n=69). Daily walking steps vs. Lower daily walking steps was evaluated on Blood pressure (morning and evening). Higher daily walking steps were associated with reduced morning systolic and diastolic blood pressure over a mean follow-up of 378 days in 69 hypertensive patients.